Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 75

1.

The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease.

Carrat F, Seksik P, Colombel JF, Peyrin-Biroulet L, Beaugerie L; CESAME Study Group.

Aliment Pharmacol Ther. 2017 Feb;45(4):533-541. doi: 10.1111/apt.13897. Epub 2016 Dec 19.

PMID:
27995656
2.

Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Bourrier A, Carrat F, Colombel JF, Bouvier AM, Abitbol V, Marteau P, Cosnes J, Simon T, Peyrin-Biroulet L, Beaugerie L; CESAME study group.

Aliment Pharmacol Ther. 2016 Jan;43(2):252-61. doi: 10.1111/apt.13466. Epub 2015 Nov 9.

3.

Interest of submucosal dissection knife for endoscopic treatment of Zenker's diverticulum.

Laquière A, Grandval P, Arpurt JP, Boulant J, Belon S, Aboukheir S, Laugier R, Penaranda G, Curel L, Boustière C.

Surg Endosc. 2015 Sep;29(9):2802-10. doi: 10.1007/s00464-014-3976-x. Epub 2014 Dec 5.

PMID:
25475517
4.

Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer.

Beaugerie L, Carrat F, Colombel JF, Bouvier AM, Sokol H, Babouri A, Carbonnel F, Laharie D, Faucheron JL, Simon T, de Gramont A, Peyrin-Biroulet L; CESAME Study Group.

Gut. 2014 Sep;63(9):1416-23. doi: 10.1136/gutjnl-2013-305763. Epub 2013 Oct 25.

PMID:
24162591
5.

Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease.

Sokol H, Beaugerie L, Maynadié M, Laharie D, Dupas JL, Flourié B, Lerebours E, Peyrin-Biroulet L, Allez M, Simon T, Carrat F, Brousse N; CESAME Study Group.

Inflamm Bowel Dis. 2012 Nov;18(11):2063-71. doi: 10.1002/ibd.22889. Epub 2012 Jan 23.

PMID:
22271569
6.

Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial.

Benamouzig R, Uzzan B, Deyra J, Martin A, Girard B, Little J, Chaussade S; Association pour la Prévention par l'Aspirine du Cancer Colorectal Study Group (APACC).

Gut. 2012 Feb;61(2):255-61. doi: 10.1136/gutjnl-2011-300113. Epub 2011 Sep 2. Erratum in: Gut. 2012 Mar;61(3):472.

PMID:
21890814
7.

Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.

Peyrin-Biroulet L, Khosrotehrani K, Carrat F, Bouvier AM, Chevaux JB, Simon T, Carbonnel F, Colombel JF, Dupas JL, Godeberge P, Hugot JP, Lémann M, Nahon S, Sabaté JM, Tucat G, Beaugerie L; Cesame Study Group.

Gastroenterology. 2011 Nov;141(5):1621-28.e1-5. doi: 10.1053/j.gastro.2011.06.050. Epub 2011 Jun 25.

PMID:
21708105
8.

Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention.

Benamouzig R, Uzzan B, Martin A, Deyra J, Little J, Girard B, Chaussade S; APACC Study Group.

Gut. 2010 May;59(5):622-9. doi: 10.1136/gut.2008.175406.

PMID:
20427397
9.

Effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice: results of a prospective cohort study.

Melin P, Chousterman M, Fontanges T, Ouzan D, Rotily M, Lang JP, Marcellin P, Cacoub P; CheObs Study Group.

Eur J Gastroenterol Hepatol. 2010 Sep;22(9):1050-7. doi: 10.1097/MEG.0b013e328338d9aa.

PMID:
20351554
10.

Intrinsic membrane properties of pre-oromotor neurons in the intermediate zone of the medullary reticular formation.

Venugopal S, Boulant JA, Chen Z, Travers JB.

Neuroscience. 2010 Jun 16;168(1):31-47. doi: 10.1016/j.neuroscience.2010.03.036. Epub 2010 Mar 22.

11.

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J, Hébuterne X, Cortot A, Bouhnik Y, Gendre JP, Simon T, Maynadié M, Hermine O, Faivre J, Carrat F; CESAME Study Group.

Lancet. 2009 Nov 7;374(9701):1617-25. doi: 10.1016/S0140-6736(09)61302-7.

PMID:
19837455
12.

Cyclic GMP alters the firing rate and thermosensitivity of hypothalamic neurons.

Wright CL, Burgoon PW, Bishop GA, Boulant JA.

Am J Physiol Regul Integr Comp Physiol. 2008 May;294(5):R1704-15. doi: 10.1152/ajpregu.00714.2007. Epub 2008 Mar 5.

13.

Carbon dioxide and pH effects on temperature-sensitive and -insensitive hypothalamic neurons.

Wright CL, Boulant JA.

J Appl Physiol (1985). 2007 Apr;102(4):1357-66. Epub 2006 Nov 30.

14.

Counterpoint: Heat-induced membrane depolarization of hypothalamic neurons: an unlikely mechanism of central thermosensitivity.

Boulant JA.

Am J Physiol Regul Integr Comp Physiol. 2006 May;290(5):R1481-4; discussion R1484. No abstract available.

15.

Ionic channels and conductance-based models for hypothalamic neuronal thermosensitivity.

Wechselberger M, Wright CL, Bishop GA, Boulant JA.

Am J Physiol Regul Integr Comp Physiol. 2006 Sep;291(3):R518-29. Erratum in: Am J Physiol Regul Integr Comp Physiol. 2007 Mar;292(3):R1376.

16.

Neuronal basis of Hammel's model for set-point thermoregulation.

Boulant JA.

J Appl Physiol (1985). 2006 Apr;100(4):1347-54. Review.

17.
18.

[Registry of liver biopsies from hepatitis C infected patients in the Alpes-Maritimes (France). Results from the first 2 years].

Mariné-Barjoan E, Fontas E, Pradier C, Ouzan D, Saint-Paul MC, Sattonnet C, Delasalle P, Boulant J, Gueyffier C, Varini JP, Bianchi D, Longo F, Michiels JF, Dellamonica P, Rampal P, Tran A.

Gastroenterol Clin Biol. 2002 Jan;26(1):57-61. French.

19.
20.

Temperature-sensitive properties of rat suprachiasmatic nucleus neurons.

Burgoon PW, Boulant JA.

Am J Physiol Regul Integr Comp Physiol. 2001 Sep;281(3):R706-15.

Supplemental Content

Loading ...
Support Center